DOSSIER · 13F-HR · Q1 2026

DIADEMA PARTNERS LP

$588M in tracked AUM across 144 positions as of Q1 2026.

DP
CIK 0002026172 · last filed Mar 31, 2026
Total AUM
$588M
as of Q1 2026
Holdings
144
positions
Whale Score
52
52
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026

DIADEMA PARTNERS LP filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
UTHR
UNITED THERAPEUTICS CORP DEL
$52M88K8.8%
02
VRTX
VERTEX PHARMACEUTICALS INC
$43M97K7.4%
03
VKTX
VIKING THERAPEUTICS INC
$39M1.2M6.6%
04
CAPR
CAPRICOR THERAPEUTICS INC
$31M1.0M5.3%
05
ABVX
ABIVAX SA
$30M276K5.2%
06
LQDA
LIQUIDIA CORPORATION
$27M712K4.6%
07
RVMD
REVOLUTION MEDICINES INC
$20M206K3.4%
08
APGE
APOGEE THERAPEUTICS INC
$19M223K3.2%
09
BBIO 1.75 03/01/31
BRIDGEBIO PHARMA INC
$19M250K3.2%
10
INCY
INCYTE CORP
$17M183K2.9%

Filing history

2026Q1Mar 31
$588M 1.2%
144 positionsView →
2025Q4Dec 31
$581M 98.6%
145 positionsView →
2025Q3Sep 30
$292M 10.9%
88 positionsView →
2025Q2Jun 30
$328M 86.1%
96 positionsLocked
2025Q1Mar 31
$176M 24.3%
69 positionsLocked
2024Q4Dec 31
$233M
107 positionsLocked